Journal of Clinical Endocrinology & Metabolism, Vol 63, 1262-1269, Copyright © 1986 by Endocrine Society

ARTICLES

Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia

ES Orwoll and DE Meier

The effects of aging on calcium and bone metabolism have not been systematically examined in men. To identify age-related alterations in vitamin D and PTH physiology and to assess their impact on skeletal health, we studied 62 normal men, aged 30-92 yr. The men were in excellent health, and none had any evidence of metabolic bone disease and/or known risk factors for osteopenia. Serum 25-hydroxyvitamin D (25OHD) concentrations declined steadily with advancing age (r = -0.47; P less than 0.001), and there was a corresponding decline in serum 24,25-dihydroxyvitamin D [24,25-(OH)2D] levels (r = -0.41; P less than 0.001). Serum 1,25-(OH)2D concentrations, however, did not vary over this age range (r = -0.07; P = NS). Plasma PTH levels increased with aging (r = -0.24; P less than 0.001), and there was a concomitant increase in urinary cAMP excretion (r = 0.38; P less than 0.001). Renal function (creatinine clearance) clearly declined with increasing age (r = -0.71; P less than 0.001). In conjunction with these changes in calcium metabolism, radial and vertebral bone mineral content declined. Whereas the fall in radial bone mineral content (single photon absorptiometry) at both proximal and distal sites was slight, there was a marked decrease in vertebral bone mineral content, as measured by quantitative computed tomography (r = -0.72; P less than 0.0001). The fall in vertebral bone mineral content correlated well with the declines in serum 25OHD and 24,25-(OH)2D concentrations (r = 0.47; P less than 0.001 and r = 0.51; P less than 0.001, respectively) and with the decline in renal function (r = 0.46; P less than 0.001). Multiple regression analysis revealed that the effects of aging on bone mineral content could be accounted for in large part by concomitant changes in mineral metabolism. Both the decline in renal function and the fall in serum 24,25-(OH)2D levels were closely associated with the fall in bone mineral content. These results indicate that a decline in renal function and alterations in vitamin D metabolism occur with aging in normal men. These changes contribute to, if not cause, the associated decline in skeletal mineral content in aging men.

This article has been cited by other articles:

				M. van Abel, S. Huybers, J. G. J. Hoenderop, A. W. C. M. van der Kemp, J. P. T. M. van Leeuwen, and R. J. M. Bindels Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6 Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1177 - F1183. [Abstract] [Full Text] [PDF]

				V. J. Wright Osteoporosis in Men J. Am. Acad. Ortho. Surg., June 1, 2006; 14(6): 347 - 353. [Abstract] [Full Text] [PDF]

				H. Blain, A. Vuillemin, A. Blain, F. Guillemin, N. D. Talance, B. Doucet, and C. Jeandel Age-Related Femoral Bone Loss in Men: Evidence for Hyperparathyroidism and Insulin-Like Growth Factor-1 Deficiency J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2004; 59(12): 1285 - 1289. [Abstract] [Full Text] [PDF]

				A. G. Need, P. D. O'Loughlin, H. A. Morris, M. Horowitz, and B. E. C. Nordin The Effects of Age and Other Variables on Serum Parathyroid Hormone in Postmenopausal Women Attending an Osteoporosis Center J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1646 - 1649. [Abstract] [Full Text] [PDF]

				Y. Takeuchi, S. Watanabe, G. Ishii, S. Takeda, K. Nakayama, S. Fukumoto, Y. Kaneta, D. Inoue, T. Matsumoto, K. Harigaya, et al. Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice J. Biol. Chem., December 6, 2002; 277(50): 49011 - 49018. [Abstract] [Full Text] [PDF]

				N. Ichioka, M. Inaba, T. Kushida, T. Esumi, K. Takahara, K. Inaba, R. Ogawa, H. Iida, and S. Ikehara Prevention of Senile Osteoporosis in SAMP6 Mice by Intrabone Marrow Injection of Allogeneic Bone Marrow Cells Stem Cells, November 1, 2002; 20(6): 542 - 551. [Abstract] [Full Text] [PDF]

				F. Scopacasa, J.M. Wishart, A.G. Need, M. Horowitz, H.A. Morris, and B.E.C. Nordin Bone Density and Bone-Related Biochemical Variables in Normal Men: A Longitudinal Study J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2002; 57(6): M385 - 391. [Abstract] [Full Text]

				B. Halloran, P. Uden, Q.-Y. Duh, S. Kikuchi, T. Wieder, J. Cao, and O. Clark Parathyroid gland volume increases with postmaturational aging in the rat Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E557 - E563. [Abstract] [Full Text] [PDF]

				D. Fatayerji, E. B. Mawer, and R. Eastell The Role of Insulin-Like Growth Factor I in Age-Related Changes in Calcium Homeostasis in Men J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4657 - 4662. [Abstract] [Full Text]

				S. Pattanaungkul, B. L. Riggs, A. L. Yergey, N. E. Vieira, W. M. O’Fallon, and S. Khosla Relationship of Intestinal Calcium Absorption to 1,25-Dihydroxyvitamin D [1,25(OH)2D] Levels in Young Versus Elderly Women: Evidence for Age-Related Intestinal Resistance to 1,25(OH)2D Action J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4023 - 4027. [Abstract] [Full Text]

				J M Kaufman, O Johnell, E Abadie, S Adami, M Audran, B Avouac, W B. Sedrine, G Calvo, J P Devogelaer, V Fuchs, et al. Background for studies on the treatment of male osteoporosis: state of the art Ann Rheum Dis, October 1, 2000; 59(10): 765 - 772. [Abstract] [Full Text]

				S. S. Harris, B. Dawson-Hughes, and G. A. Perrone Plasma 25-Hydroxyvitamin D Responses of Younger and Older Men to Three Weeks of Supplementation with 1800 IU/day of Vitamin D J. Am. Coll. Nutr., October 1, 1999; 18(5): 470 - 474. [Abstract] [Full Text] [PDF]